Translational Biology
A locked, documented, transferable assay - not a protocol that only works here
USD 25–90K · 8–16 weeks · Validated protocol, validation report, technology transfer and training
At a glance
- Price band
- USD 25–90K
- Duration
- 8–16 weeks
- Deliverable
- Locked, validated protocol
- Included
- Transfer + training
Indicative list price. Final scope and price confirmed in the proposal.
Talk to a scientistThe problem
Why teams buy this
Off-the-shelf assays rarely match your target, your sample matrix or your multiplexing requirement. In-house development consumes scarce laboratory time, and assays that work on one operator’s bench often do not survive transfer.
What you get
Deliverables, not activity
- A validated assay protocol with a complete reagent list
- An analytical validation report: limit of detection, linearity, precision, specificity
- Primer and probe sequences - yours
- A technology-transfer package and training for your team
How it works
The sequence
Requirement and specification definitionIn-silico primer and probe design with specificity checksWet-lab optimisation and multiplexingAnalytical validationProtocol lock and transfer
Who this is for
Diagnostics companies · hospital and public health laboratories · biotech · agricultural and veterinary laboratories.
Proof
Representative result
A five-target respiratory multiplex validated to a limit of detection of 50 copies per reaction and transferred to the customer's laboratory in nine weeks.
Representative programme - illustrates typical scope and outcomes; not an individual client account. Client-specific references are available on request under confidentiality.
Enterprise AI for Life Sciences
Ready to Advance Your Drug Discovery Pipeline?
Partner with Prognica Labs to leverage enterprise-grade AI, computational chemistry, and molecular simulation technologies that accelerate discovery, reduce development risk, and improve R&D productivity.
From biotech startups to global pharmaceutical organizations, we help research teams make faster, evidence-driven decisions across every stage of early drug discovery.